Genomic analysis of primary tumors does not address the prevalence of metastatic cells in the population - PubMed (original) (raw)

Comment

. 2003 May;34(1):23; author reply 25.

doi: 10.1038/ng0503-23a.

• PMID: 12721548
• DOI: 10.1038/ng0503-23a

Comment

Genomic analysis of primary tumors does not address the prevalence of metastatic cells in the population

Isaiah J Fidler et al. Nat Genet. 2003 May.

No abstract available

PubMed Disclaimer

Comment on

• A molecular signature of metastasis in primary solid tumors.
  Ramaswamy S, Ross KN, Lander ES, Golub TR. Ramaswamy S, et al. Nat Genet. 2003 Jan;33(1):49-54. doi: 10.1038/ng1060. Epub 2002 Dec 9. Nat Genet. 2003. PMID: 12469122

Similar articles

• Genetic background is an important determinant of metastatic potential.
  Hunter K, Welch DR, Liu ET. Hunter K, et al. Nat Genet. 2003 May;34(1):23-4; author reply 25. doi: 10.1038/ng0503-23b. Nat Genet. 2003. PMID: 12721549 No abstract available.
• Road map to metastasis.
  Van't Veer LJ, Weigelt B. Van't Veer LJ, et al. Nat Med. 2003 Aug;9(8):999-1000. doi: 10.1038/nm0803-999b. Nat Med. 2003. PMID: 12894162 No abstract available.
• Molecular targets in metastasis: lessons from genomic approaches.
  Fingleton B. Fingleton B. Cancer Genomics Proteomics. 2007 May-Jun;4(3):211-21. Cancer Genomics Proteomics. 2007. PMID: 17878524 Review.
• Adaptation versus selection: the origins of metastatic behavior.
  Scheel C, Onder T, Karnoub A, Weinberg RA. Scheel C, et al. Cancer Res. 2007 Dec 15;67(24):11476-9; discussion 11479-80. doi: 10.1158/0008-5472.CAN-07-1653. Cancer Res. 2007. PMID: 18089773 Review. No abstract available.
• Fibronectin is distinctly downregulated in murine mammary adenocarcinoma cells with high metastatic potential.
  Urtreger AJ, Werbajh SE, Verrecchia F, Mauviel A, Puricelli LI, Kornblihtt AR, Bal de Kier Joffé ED. Urtreger AJ, et al. Oncol Rep. 2006 Dec;16(6):1403-10. Oncol Rep. 2006. PMID: 17089068

Cited by

• LncRNA IPW inhibits growth of ductal carcinoma in situ by downregulating ID2 through miR-29c.
  Deshpande RP, Sharma S, Liu Y, Pandey PR, Pei X, Wu K, Wu SY, Tyagi A, Zhao D, Mo YY, Watabe K. Deshpande RP, et al. Breast Cancer Res. 2022 Jan 25;24(1):6. doi: 10.1186/s13058-022-01504-4. Breast Cancer Res. 2022. PMID: 35078502 Free PMC article.
• Reduced expression of odd-skipped related transcription factor 1 promotes proliferation and invasion of breast cancer cells and indicates poor patient prognosis.
  Wang Y, Lei L, Xu F, Xu HT. Wang Y, et al. Oncol Lett. 2020 Sep;20(3):2946-2954. doi: 10.3892/ol.2020.11820. Epub 2020 Jul 7. Oncol Lett. 2020. PMID: 32782611 Free PMC article.
• Odd-skipped related 1 inhibits lung cancer proliferation and invasion by reducing Wnt signaling through the suppression of SOX9 and β-catenin.
  Wang Y, Lei L, Zheng YW, Zhang L, Li ZH, Shen HY, Jiang GY, Zhang XP, Wang EH, Xu HT. Wang Y, et al. Cancer Sci. 2018 Jun;109(6):1799-1810. doi: 10.1111/cas.13614. Epub 2018 May 23. Cancer Sci. 2018. PMID: 29660200 Free PMC article.
• Analysis of molecular markers as predictive factors of lymph node involvement in breast carcinoma.
  Paula LM, De Moraes LH, Do Canto AL, Dos Santos L, Martin AA, Rogatto SR, De Azevedo Canevari R. Paula LM, et al. Oncol Lett. 2017 Jan;13(1):488-496. doi: 10.3892/ol.2016.5438. Epub 2016 Nov 28. Oncol Lett. 2017. PMID: 28123587 Free PMC article.
• CRKL overexpression promotes cell proliferation and inhibits apoptosis in endometrial carcinoma.
  Cai L, Wang H, Yang Q. Cai L, et al. Oncol Lett. 2017 Jan;13(1):51-56. doi: 10.3892/ol.2016.5394. Epub 2016 Nov 17. Oncol Lett. 2017. PMID: 28123521 Free PMC article.

Publication types

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group

• Other Literature Sources

  • The Lens - Patent Citations